Cancer registry abstract services

Ended Purchase Order Awarded Last action

Contract number
W81K0021P0260
Awardee
Awarding agency
Obligated
$844,750

Award facts

Opportunity
Contract value 100% obligated
$844,750.04 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Funding agency
Defense Health Agency Department of Defense
Set-aside
Woman-Owned Small Business
Competition
Competed under SAP · 3 offers Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
JBSA FT SAM HOUSTON, TX 78234, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00013 $0
Funding Only Action P00012 $175,500
Exercise an Option P00011 · Exercise option year 4 - cancer registry $0
Funding Only Action P00010 · Cancer registry abstract services - FY25 funding $175,500
Exercise an Option P00009 · Cancer registry abstract services -- option year 3 $0
Funding Only Action P00008 $175,500
Exercise an Option P00007 $0
Funding Only Action P00006 -$32,750
Funding Only Action P00005 $175,500
Other Administrative Action P00004 $0
Exercise an Option P00003 $0
Other Administrative Action P00002 $0
Funding Only Action P00001 $175,500
Original award $0
Show all 14

About this award

The Defense Health Agency awarded a purchase order to Onco Inc., a woman-owned small business, on September 17, 2021, under a Woman-Owned Small Business set-aside. The firm fixed-price order carries a ceiling value of $844,750.04 and exercises option year 4 for cancer registry abstract services. Performance is at JBSA Fort Sam Houston, Texas, with an ultimate completion date of September 30, 2026, which precedes today's date of October 26, 2026. The work covers abstracting new cancer cases and providing quality oversight and management of registry services under the performance work statement. The order originated from a U.S. Army Medical Command solicitation for Brooke Army Medical Center, posted July 16, 2021, with proposals due August 17, 2021. The solicitation's base period ran October 2021 through September 2022, with four one-year options extending to September 2026.

Quick answers

Who was awarded contract W81K0021P0260?

W81K0021P0260 was awarded to Onco Inc. by Medical Command (Department of the Army) on September 17, 2021.

How much is contract W81K0021P0260 worth?

The government has obligated $844,750 on W81K0021P0260.

Which agency awarded contract W81K0021P0260?

Medical Command (Department of the Army) awarded W81K0021P0260, with funding from Defense Health Agency (Department of Defense).

Was contract W81K0021P0260 competed?

The extent of competition for W81K0021P0260 was competed under sap. The government received 3 offers. It was set aside: Woman-Owned Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award